Table 1. Comparison of preoperative data.

		Group 1 (n=50)	Group 2 (n=50)	P
Age (years) [median (min-max)]		65.5 (51-74)	64 (45-76)	0.407*
MCCI [median (min-max)]		4 (3-6)	4 (2-6)	0.375*
Previous abdominal surgery, n(%)		10 (20)	2 (4)	0.014**
Previous prostate surgery, n(%)		2 (4)	–	0.495***
Prostate volume (cc) [median (min-max)]		55 (24-120)	50 (18-100)	0.158*
Presence of median lob hypertrophy, n(%)		12 (24)	3 (6)	0.012**
PSA (ng/dL) [median (min-max)]		7.6 (6. 8-37.79)	6.43 (1.41-27)	0.461*
Preoperative Gleason score, n(%)	6	33 (66)	35 (70)	0.436***
	7	15 (30)	10 (20)
	8-10	2 (4)	5 (10)
Positive core (n) [median (min-max)]		4 (0-12)	3 (1-12)	0.437*
Clinical stage, n(%)	T1b	1 (2)	0 (0)	0.001**
	T1c	14 (28)	36 (72)
	T2a	19 (38)	9 (18)
	T2b	8 (16)	0 (0)
	T2c	8 (16)	5 (10)

MCCI = Modified Charlson comorbidity index; PSA = Prostate specific antigen

^*= Mann-Whitney U

^**= Chi-Square Test

^***= Fisher's Exact Test